What is the appropriate evaluation and management for a patient with recurrent severe neutropenia (white blood cell count as low as 0.89 × 10⁹/L with neutrophils 15%) and otherwise normal red blood cell and platelet counts?

Severe Recurrent Neutropenia with Lymphocyte Predominance

This patient requires urgent comprehensive evaluation for an underlying hematologic disorder, autoimmune condition, or chronic idiopathic neutropenia, with immediate consideration for bone marrow biopsy and granulocyte colony-stimulating factor (G-CSF) therapy given the severe neutropenia (ANC as low as 134/μL) and infection risk.

Immediate Risk Assessment

Your patient has severe neutropenia (ANC <500/mm³) based on the most recent values:

• Most recent: WBC 0.89 with 15% neutrophils = ANC ~134/μL (Grade 4, very severe)
• Prior: WBC 1.49 with 44% neutrophils = ANC ~656/μL (severe)
• Latest: WBC 1.92 with 25% neutrophils = ANC ~480/μL (severe)

The lymphocyte predominance (66-70%) with severe neutropenia and normal RBC/platelets suggests selective neutrophil suppression rather than global marrow failure 1, 2.

Critical Diagnostic Workup

Essential Immediate Testing:

• Bone marrow aspiration and biopsy with cytogenetics - mandatory to exclude myelodysplasia, leukemia, or marrow infiltration 2, 3
• Antineutrophil antibody testing - evaluate for autoimmune neutropenia (interpret only with bone marrow findings) 4
• Comprehensive medication review - idiosyncratic drug-induced neutropenia is common 1, 3
• Infectious workup: HIV, hepatitis panel, EBV, CMV, parvovirus B19 1, 2
• Nutritional assessment: vitamin B12, folate, copper levels 1
• Autoimmune markers: ANA, rheumatoid factor, anti-dsDNA if clinical suspicion 2

Consider Genetic Testing If:

• Age <40 years
• Family history of neutropenia or recurrent infections
• Poor response to standard interventions
• Bone marrow shows maturation arrest 4, 5

Infection Risk Management

With ANC <500/mm³, this patient has high infection risk requiring immediate protective measures 6, 7:

Fever Protocol:

• Febrile neutropenia definition: Single temperature ≥38.3°C (101°F) OR ≥38.0°C (100.4°F) for ≥1 hour with ANC <500/mm³ 6
• This is an oncologic emergency requiring immediate broad-spectrum antibiotics 1
• Empiric therapy options: cefepime, ceftazidime, imipenem, or meropenem 6

Prophylactic Measures:

• Avoid invasive procedures when possible
• Meticulous oral hygiene (periodontium is common infection site) 6
• Monitor for subtle infection signs: pain at common sites (pharynx, esophagus, perineum, catheter sites) 6
• Note: Inflammatory signs may be minimal or absent with severe neutropenia 6

Treatment Algorithm

Step 1: Address Reversible Causes

• Stop all potentially offending medications immediately 1, 3
• Correct nutritional deficiencies if identified
• Treat active infections

Step 2: G-CSF Therapy Initiation

G-CSF (filgrastim) is indicated for severe chronic neutropenia with recurrent infections or ANC persistently <500/mm³ 8, 2, 5:

Dosing strategy 5:

• Start: 3-5 mcg/kg/day subcutaneously for idiopathic/autoimmune neutropenia
• Target ANC: 1,000-1,500/mm³ (low-normal range)
• Adjust dose based on response; some patients respond to alternate-day or thrice-weekly dosing
• Congenital neutropenia typically requires higher doses (3-10 mcg/kg/day)

Expected response 5:

• Most patients achieve ANC normalization within days to weeks
• Responses are typically durable with stable dosing over years

Step 3: Monitor for Complications

Common G-CSF adverse effects 5:

• Bone pain, arthralgias, myalgias (usually diminish after first weeks)
• Splenomegaly (monitor clinically)
• Rare: osteoporosis, vasculitis, glomerulonephritis

Critical long-term monitoring 5:

• Congenital neutropenia: 13% cumulative risk of MDS/AML after 8 years of G-CSF (no predictable relationship to dose/duration)
• Cyclic and idiopathic neutropenia: Virtually NO risk of MDS/AML evolution
• Serial CBC monitoring every 3-6 months
• Annual bone marrow if cytogenetic abnormalities develop

Differential Diagnosis Priority

Based on the pattern (severe neutropenia, lymphocyte predominance, normal other lines):

Most likely diagnoses:

1. Chronic idiopathic neutropenia - diagnosis of exclusion after workup 4
2. Autoimmune neutropenia - especially if positive antineutrophil antibodies 2, 4
3. Drug-induced neutropenia - review ALL medications including over-the-counter 1, 3
4. Post-infectious neutropenia - may persist weeks after viral illness 1

Must exclude:

• Large granular lymphocyte (LGL) leukemia - can present with isolated neutropenia and lymphocytosis 2, 9
• Early MDS - requires bone marrow evaluation 3
• Nutritional deficiency (B12, folate, copper) 1

Common Pitfalls to Avoid

1. Delaying bone marrow biopsy - this is NOT optional with severe recurrent neutropenia and must be done to exclude malignancy 2, 3

2. Waiting for fever before acting - with ANC <500/mm³, prophylactic G-CSF should be considered even without infection history 7, 2

3. Misinterpreting lymphocyte predominance - relative lymphocytosis with severe neutropenia suggests selective neutrophil problem, not lymphoproliferative disorder (unless absolute lymphocyte count is elevated) 9

4. Overlooking medication causes - systematically review ALL drugs, including recent additions and seemingly benign medications 3

5. Inadequate infection surveillance - patients may have serious infections with minimal inflammatory signs due to absent neutrophils 6

When to Consider Hematology Referral

Immediate referral indicated (this patient meets criteria):

• ANC persistently <500/mm³ 2
• Recurrent severe infections
• Need for bone marrow evaluation
• Consideration of G-CSF therapy
• Any concern for underlying hematologic malignancy